Moxidectin combination therapy outperforms albendazole monotherapy for treating whipworm (trichuriasis) in school-aged children: www.thelancet.com/journals/lan...
Efficacy and safety of moxidectin–albendazole combination therapy for Trichuris trichiura infections in school-aged children: a double-blind, randomised, controlled, superiority trial
Moxidectin-albendazole combination therapy was superior to albendazole monotherapy
in terms of efficacy in the treatment of trichuriasis in school-aged children. Both
treatments presented a similar sa...
www.thelancet.com
July 18, 2025 at 10:00 AM
Moxidectin combination therapy outperforms albendazole monotherapy for treating whipworm (trichuriasis) in school-aged children: www.thelancet.com/journals/lan...
In a Phase 2 clinical trial, WashU and Ivorian researchers find moxidectin, a new medicine for river blindness, also works for lymphatic filariasis www.thelancet.com/journals/lan...
Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial
In this study, single-dose MoxA was superior to IA for W bancrofti microfilaria clearance
at 12 months and provided prolonged microfilaria clearance for most participants.
These results suggest that M...
www.thelancet.com
May 7, 2025 at 10:03 PM
In a Phase 2 clinical trial, WashU and Ivorian researchers find moxidectin, a new medicine for river blindness, also works for lymphatic filariasis www.thelancet.com/journals/lan...
Reposted by George Rugarabamu
A new river blindness medicine is being introduced by a nonprofit pharmaceutical company in Ghana.
Innovative finance brings new river blindness medicine to Africa
Innovative finance brings new river blindness medicine to Africa
www.devex.com
February 27, 2025 at 10:30 PM
A new river blindness medicine is being introduced by a nonprofit pharmaceutical company in Ghana.
'Innovative finance brings new river blindness medicine to Africa.' A @devex.com story about recent milestones at MDGH www.devex.com/news/innovat...
Innovative finance brings new river blindness medicine to Africa
A new river blindness medicine is being introduced by a nonprofit pharmaceutical company in Ghana.
www.devex.com
February 28, 2025 at 5:25 AM
'Innovative finance brings new river blindness medicine to Africa.' A @devex.com story about recent milestones at MDGH www.devex.com/news/innovat...
Ghana rolls out moxidectin, a new treatment for river blindness www.medicinesdevelopment.com/news/momentum
January 29, 2025 at 8:12 AM
Ghana rolls out moxidectin, a new treatment for river blindness www.medicinesdevelopment.com/news/momentum
Not-for-profit pharmaceutical company MDGH receives first endemic country approval for a new river blindness treatment www.medicinesdevelopment.com/news/ghana-b...
Ghana becomes first river blindness-endemic country to approve moxidectin | News | Medicines Development for Global Health
Medicines Development for Global Health (MDGH) announced today that the Ghana Food and Drugs Authority (FDA) approved moxidectin 2 mg oral tables for the treatment of river blindness (onchocerciasis) ...
www.medicinesdevelopment.com
December 9, 2024 at 10:47 AM
Not-for-profit pharmaceutical company MDGH receives first endemic country approval for a new river blindness treatment www.medicinesdevelopment.com/news/ghana-b...